113 related articles for article (PubMed ID: 7359321)
1. Impurities in drugs IV: Indomethacin.
Curran NM; Lovering EG; McErlane KM; Watson JR
J Pharm Sci; 1980 Feb; 69(2):187-9. PubMed ID: 7359321
[TBL] [Abstract][Full Text] [Related]
2. HPLC analysis of indomethacin and its impurities in capsule and suppository formulations.
Kwong E; Pillai GK; McErlane KM
J Pharm Sci; 1982 Jul; 71(7):828-30. PubMed ID: 7120076
[TBL] [Abstract][Full Text] [Related]
3. Impurities in drugs V: Meprobamate.
Lawrence RC; Lovering EG; Poirier MA; Watson JR
J Pharm Sci; 1980 Dec; 69(12):1444-5. PubMed ID: 7463335
[TBL] [Abstract][Full Text] [Related]
4. Impurities in drugs I: Imipramine, desipramine, and their formulations.
McErlane KM; Curran NM; Lovering EG
J Pharm Sci; 1977 Jul; 66(7):1015-8. PubMed ID: 886436
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous densitometric determination of indomethacin and its degradation products, 4-chlorobenzoic acid and 5-methoxy-2-methyl-3-indoleacetic acid, in pharmaceutical preparations.
Krzek J; Starek M
J AOAC Int; 2001; 84(6):1703-7. PubMed ID: 11767134
[TBL] [Abstract][Full Text] [Related]
6. Impurities in drugs III: Trihexyphenidyl.
Poirier MA; Curran NM; McErlane KM; Lovering EG
J Pharm Sci; 1979 Sep; 68(9):1124-7. PubMed ID: 501534
[TBL] [Abstract][Full Text] [Related]
7. Characterization of impurities in sulfasalazine.
Zalipsky JJ; Patel DM; Reavey-Cantwell NH
J Pharm Sci; 1978 Mar; 67(3):387-91. PubMed ID: 25326
[TBL] [Abstract][Full Text] [Related]
8. Impurities in drugs II: meperidine and its formulations.
McErlane KM; Wood RJ; Matsui F; Lovering EG
J Pharm Sci; 1978 Jul; 67(7):958-61. PubMed ID: 660515
[TBL] [Abstract][Full Text] [Related]
9. Studies on improvement of pharmaceutical preparations prescribed in hospitals. V. Nifedipine hollow type suppository.
Namiki N; Yokoyama H; Moriya K; Fukuda M; Takashima T; Tamura H; Yuasa H; Kanaya Y
Drug Des Deliv; 1986 Nov; 1(2):167-73. PubMed ID: 3509330
[TBL] [Abstract][Full Text] [Related]
10. Development of micellar electrokinetic chromatography method for the determination of three defined impurities in indomethacin.
Riasová P; Doubková D; Pincová L; Jung O; Polášek M; Jáč P
Electrophoresis; 2018 Oct; 39(20):2550-2557. PubMed ID: 29664166
[TBL] [Abstract][Full Text] [Related]
11. [Preformulatory research on model soft gel capsule containing liquid filling with constant ibuprofen content].
Dobrzyński ŁJ; Zgoda MM
Polim Med; 2011; 41(1):67-71. PubMed ID: 21744659
[TBL] [Abstract][Full Text] [Related]
12. Identification, isolation and characterization of process related impurities in ezetimibe.
Guntupalli S; Ray UK; Murali N; Gupta PB; Kumar VJ; Satheesh D; Islam A
J Pharm Biomed Anal; 2014 Jan; 88():385-90. PubMed ID: 24176742
[TBL] [Abstract][Full Text] [Related]
13. Isolation and identification of three potential impurities of pholcodine bulk drug substance.
Denk OM; Gray AI; Skellern GG; Watson DG
J Pharm Pharmacol; 2000 Jul; 52(7):819-29. PubMed ID: 10933132
[TBL] [Abstract][Full Text] [Related]
14. Drug-excipient compatibility testing-Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold.
Douša M; Gibala P; Havlíček J; Plaček L; Tkadlecová M; Břicháč J
J Pharm Biomed Anal; 2011 Jul; 55(5):949-56. PubMed ID: 21481557
[TBL] [Abstract][Full Text] [Related]
15. Aspirin--a national survey V: Determination of aspirin and impurities in enteric coated tablets and suppository formulations and in vitro dissolution of enteric coated tablets.
Kirchhoefer RD; Jefferson E; Flinn PE
J Pharm Sci; 1982 Sep; 71(9):1049-52. PubMed ID: 7131273
[TBL] [Abstract][Full Text] [Related]
16. In vitro drug liberation and kinetics of sustained release indomethacin suppository.
Uzunkaya G; Bergişadi N
Farmaco; 2003 Jul; 58(7):509-12. PubMed ID: 12818689
[TBL] [Abstract][Full Text] [Related]
17. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
18. Elemental Impurities in Pharmaceutical Excipients.
Li G; Schoneker D; Ulman KL; Sturm JJ; Thackery LM; Kauffman JF
J Pharm Sci; 2015 Dec; 104(12):4197-4206. PubMed ID: 26398581
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of degradation products of dicloxacillin in bulk drug and pharmaceutical dosage forms.
Raj TJ; Bharati CH; Rao KR; Rao PS; Narayan GK; Parikh K
J Pharm Biomed Anal; 2007 Mar; 43(4):1470-5. PubMed ID: 17125952
[TBL] [Abstract][Full Text] [Related]
20. Impurities in illicit amphetamine: review.
Sinnema A; Verweij AM
Bull Narc; 1981; 33(3):37-54. PubMed ID: 7039749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
